Female Infertility Diagnosis and Treatment Market, Global Outlook and Forecast 2022-2028

March 2022 | 105 pages | ID: FA6A1BCC6CB1EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Female Infertility Diagnosis and Treatment in Global, including the following market information:

Global Female Infertility Diagnosis and Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Female Infertility Diagnosis and Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Drugs and medicine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Female Infertility Diagnosis and Treatment include Bayer, Bristol-Myers Squibb, Church & Dwight, Cook Medical, CooperSurgical, Eli Lilly, EMD Serono, Endo and Ferring Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Female Infertility Diagnosis and Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Female Infertility Diagnosis and Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Female Infertility Diagnosis and Treatment Market Segment Percentages, by Type, 2021 (%)

• Drugs and medicine
• Surgical
• Intrauterine insemination (IUI)
• Assisted reproductive technology (ART)

Global Female Infertility Diagnosis and Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Female Infertility Diagnosis and Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals and Clinics
• Diagnostic Centers

Global Female Infertility Diagnosis and Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Female Infertility Diagnosis and Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Female Infertility Diagnosis and Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Female Infertility Diagnosis and Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bayer
• Bristol-Myers Squibb
• Church & Dwight
• Cook Medical
• CooperSurgical
• Eli Lilly
• EMD Serono
• Endo
• Ferring Pharmaceuticals
• Genea
• GSK
• Halotech DNA
• Irvine Scientific
• Janssen
• Merck
• Novartis
• Origio
• Pfizer
• OvaScience

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Female Infertility Diagnosis and Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Female Infertility Diagnosis and Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FEMALE INFERTILITY DIAGNOSIS AND TREATMENT OVERALL MARKET SIZE

2.1 Global Female Infertility Diagnosis and Treatment Market Size: 2021 VS 2028
2.2 Global Female Infertility Diagnosis and Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Female Infertility Diagnosis and Treatment Players in Global Market
3.2 Top Global Female Infertility Diagnosis and Treatment Companies Ranked by Revenue
3.3 Global Female Infertility Diagnosis and Treatment Revenue by Companies
3.4 Top 3 and Top 5 Female Infertility Diagnosis and Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Female Infertility Diagnosis and Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Female Infertility Diagnosis and Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Female Infertility Diagnosis and Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Female Infertility Diagnosis and Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Female Infertility Diagnosis and Treatment Market Size Markets, 2021 & 2028
  4.1.2 Drugs and medicine
  4.1.3 Surgical
  4.1.4 Intrauterine insemination (IUI)
  4.1.5 Assisted reproductive technology (ART)
4.2 By Type - Global Female Infertility Diagnosis and Treatment Revenue & Forecasts
  4.2.1 By Type - Global Female Infertility Diagnosis and Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Female Infertility Diagnosis and Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Female Infertility Diagnosis and Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals and Clinics
  5.1.3 Diagnostic Centers
5.2 By Application - Global Female Infertility Diagnosis and Treatment Revenue & Forecasts
  5.2.1 By Application - Global Female Infertility Diagnosis and Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Female Infertility Diagnosis and Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Female Infertility Diagnosis and Treatment Market Size, 2021 & 2028
6.2 By Region - Global Female Infertility Diagnosis and Treatment Revenue & Forecasts
  6.2.1 By Region - Global Female Infertility Diagnosis and Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Female Infertility Diagnosis and Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Female Infertility Diagnosis and Treatment Revenue, 2017-2028
  6.3.2 US Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.3.3 Canada Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.3.4 Mexico Female Infertility Diagnosis and Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Female Infertility Diagnosis and Treatment Revenue, 2017-2028
  6.4.2 Germany Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.4.3 France Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.4.4 U.K. Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.4.5 Italy Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.4.6 Russia Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.4.8 Benelux Female Infertility Diagnosis and Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Female Infertility Diagnosis and Treatment Revenue, 2017-2028
  6.5.2 China Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.5.3 Japan Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.5.4 South Korea Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.5.6 India Female Infertility Diagnosis and Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Female Infertility Diagnosis and Treatment Revenue, 2017-2028
  6.6.2 Brazil Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.6.3 Argentina Female Infertility Diagnosis and Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Female Infertility Diagnosis and Treatment Revenue, 2017-2028
  6.7.2 Turkey Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.7.3 Israel Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Female Infertility Diagnosis and Treatment Market Size, 2017-2028
  6.7.5 UAE Female Infertility Diagnosis and Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Bayer
  7.1.1 Bayer Corporate Summary
  7.1.2 Bayer Business Overview
  7.1.3 Bayer Female Infertility Diagnosis and Treatment Major Product Offerings
  7.1.4 Bayer Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.1.5 Bayer Key News
7.2 Bristol-Myers Squibb
  7.2.1 Bristol-Myers Squibb Corporate Summary
  7.2.2 Bristol-Myers Squibb Business Overview
  7.2.3 Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Major Product Offerings
  7.2.4 Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bristol-Myers Squibb Key News
7.3 Church & Dwight
  7.3.1 Church & Dwight Corporate Summary
  7.3.2 Church & Dwight Business Overview
  7.3.3 Church & Dwight Female Infertility Diagnosis and Treatment Major Product Offerings
  7.3.4 Church & Dwight Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.3.5 Church & Dwight Key News
7.4 Cook Medical
  7.4.1 Cook Medical Corporate Summary
  7.4.2 Cook Medical Business Overview
  7.4.3 Cook Medical Female Infertility Diagnosis and Treatment Major Product Offerings
  7.4.4 Cook Medical Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.4.5 Cook Medical Key News
7.5 CooperSurgical
  7.5.1 CooperSurgical Corporate Summary
  7.5.2 CooperSurgical Business Overview
  7.5.3 CooperSurgical Female Infertility Diagnosis and Treatment Major Product Offerings
  7.5.4 CooperSurgical Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.5.5 CooperSurgical Key News
7.6 Eli Lilly
  7.6.1 Eli Lilly Corporate Summary
  7.6.2 Eli Lilly Business Overview
  7.6.3 Eli Lilly Female Infertility Diagnosis and Treatment Major Product Offerings
  7.6.4 Eli Lilly Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.6.5 Eli Lilly Key News
7.7 EMD Serono
  7.7.1 EMD Serono Corporate Summary
  7.7.2 EMD Serono Business Overview
  7.7.3 EMD Serono Female Infertility Diagnosis and Treatment Major Product Offerings
  7.7.4 EMD Serono Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.7.5 EMD Serono Key News
7.8 Endo
  7.8.1 Endo Corporate Summary
  7.8.2 Endo Business Overview
  7.8.3 Endo Female Infertility Diagnosis and Treatment Major Product Offerings
  7.8.4 Endo Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.8.5 Endo Key News
7.9 Ferring Pharmaceuticals
  7.9.1 Ferring Pharmaceuticals Corporate Summary
  7.9.2 Ferring Pharmaceuticals Business Overview
  7.9.3 Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Major Product Offerings
  7.9.4 Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.9.5 Ferring Pharmaceuticals Key News
7.10 Genea
  7.10.1 Genea Corporate Summary
  7.10.2 Genea Business Overview
  7.10.3 Genea Female Infertility Diagnosis and Treatment Major Product Offerings
  7.10.4 Genea Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.10.5 Genea Key News
7.11 GSK
  7.11.1 GSK Corporate Summary
  7.11.2 GSK Business Overview
  7.11.3 GSK Female Infertility Diagnosis and Treatment Major Product Offerings
  7.11.4 GSK Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.11.5 GSK Key News
7.12 Halotech DNA
  7.12.1 Halotech DNA Corporate Summary
  7.12.2 Halotech DNA Business Overview
  7.12.3 Halotech DNA Female Infertility Diagnosis and Treatment Major Product Offerings
  7.12.4 Halotech DNA Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.12.5 Halotech DNA Key News
7.13 Irvine Scientific
  7.13.1 Irvine Scientific Corporate Summary
  7.13.2 Irvine Scientific Business Overview
  7.13.3 Irvine Scientific Female Infertility Diagnosis and Treatment Major Product Offerings
  7.13.4 Irvine Scientific Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.13.5 Irvine Scientific Key News
7.14 Janssen
  7.14.1 Janssen Corporate Summary
  7.14.2 Janssen Business Overview
  7.14.3 Janssen Female Infertility Diagnosis and Treatment Major Product Offerings
  7.14.4 Janssen Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.14.5 Janssen Key News
7.15 Merck
  7.15.1 Merck Corporate Summary
  7.15.2 Merck Business Overview
  7.15.3 Merck Female Infertility Diagnosis and Treatment Major Product Offerings
  7.15.4 Merck Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.15.5 Merck Key News
7.16 Novartis
  7.16.1 Novartis Corporate Summary
  7.16.2 Novartis Business Overview
  7.16.3 Novartis Female Infertility Diagnosis and Treatment Major Product Offerings
  7.16.4 Novartis Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.16.5 Novartis Key News
7.17 Origio
  7.17.1 Origio Corporate Summary
  7.17.2 Origio Business Overview
  7.17.3 Origio Female Infertility Diagnosis and Treatment Major Product Offerings
  7.17.4 Origio Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.17.5 Origio Key News
7.18 Pfizer
  7.18.1 Pfizer Corporate Summary
  7.18.2 Pfizer Business Overview
  7.18.3 Pfizer Female Infertility Diagnosis and Treatment Major Product Offerings
  7.18.4 Pfizer Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.18.5 Pfizer Key News
7.19 OvaScience
  7.19.1 OvaScience Corporate Summary
  7.19.2 OvaScience Business Overview
  7.19.3 OvaScience Female Infertility Diagnosis and Treatment Major Product Offerings
  7.19.4 OvaScience Female Infertility Diagnosis and Treatment Revenue in Global Market (2017-2022)
  7.19.5 OvaScience Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Female Infertility Diagnosis and Treatment Market Opportunities & Trends in Global Market
Table 2. Female Infertility Diagnosis and Treatment Market Drivers in Global Market
Table 3. Female Infertility Diagnosis and Treatment Market Restraints in Global Market
Table 4. Key Players of Female Infertility Diagnosis and Treatment in Global Market
Table 5. Top Female Infertility Diagnosis and Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Female Infertility Diagnosis and Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Female Infertility Diagnosis and Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Female Infertility Diagnosis and Treatment Product Type
Table 9. List of Global Tier 1 Female Infertility Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Female Infertility Diagnosis and Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Female Infertility Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Female Infertility Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Female Infertility Diagnosis and Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Female Infertility Diagnosis and Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Female Infertility Diagnosis and Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Female Infertility Diagnosis and Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Female Infertility Diagnosis and Treatment Product Offerings
Table 32. Bayer Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bristol-Myers Squibb Corporate Summary
Table 34. Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Product Offerings
Table 35. Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Church & Dwight Corporate Summary
Table 37. Church & Dwight Female Infertility Diagnosis and Treatment Product Offerings
Table 38. Church & Dwight Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Cook Medical Corporate Summary
Table 40. Cook Medical Female Infertility Diagnosis and Treatment Product Offerings
Table 41. Cook Medical Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 42. CooperSurgical Corporate Summary
Table 43. CooperSurgical Female Infertility Diagnosis and Treatment Product Offerings
Table 44. CooperSurgical Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Eli Lilly Corporate Summary
Table 46. Eli Lilly Female Infertility Diagnosis and Treatment Product Offerings
Table 47. Eli Lilly Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 48. EMD Serono Corporate Summary
Table 49. EMD Serono Female Infertility Diagnosis and Treatment Product Offerings
Table 50. EMD Serono Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Endo Corporate Summary
Table 52. Endo Female Infertility Diagnosis and Treatment Product Offerings
Table 53. Endo Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Ferring Pharmaceuticals Corporate Summary
Table 55. Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Product Offerings
Table 56. Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Genea Corporate Summary
Table 58. Genea Female Infertility Diagnosis and Treatment Product Offerings
Table 59. Genea Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 60. GSK Corporate Summary
Table 61. GSK Female Infertility Diagnosis and Treatment Product Offerings
Table 62. GSK Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Halotech DNA Corporate Summary
Table 64. Halotech DNA Female Infertility Diagnosis and Treatment Product Offerings
Table 65. Halotech DNA Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Irvine Scientific Corporate Summary
Table 67. Irvine Scientific Female Infertility Diagnosis and Treatment Product Offerings
Table 68. Irvine Scientific Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Janssen Corporate Summary
Table 70. Janssen Female Infertility Diagnosis and Treatment Product Offerings
Table 71. Janssen Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Merck Corporate Summary
Table 73. Merck Female Infertility Diagnosis and Treatment Product Offerings
Table 74. Merck Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 75. Novartis Corporate Summary
Table 76. Novartis Female Infertility Diagnosis and Treatment Product Offerings
Table 77. Novartis Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 78. Origio Corporate Summary
Table 79. Origio Female Infertility Diagnosis and Treatment Product Offerings
Table 80. Origio Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 81. Pfizer Corporate Summary
Table 82. Pfizer Female Infertility Diagnosis and Treatment Product Offerings
Table 83. Pfizer Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)
Table 84. OvaScience Corporate Summary
Table 85. OvaScience Female Infertility Diagnosis and Treatment Product Offerings
Table 86. OvaScience Female Infertility Diagnosis and Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Female Infertility Diagnosis and Treatment Segment by Type in 2021
Figure 2. Female Infertility Diagnosis and Treatment Segment by Application in 2021
Figure 3. Global Female Infertility Diagnosis and Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Female Infertility Diagnosis and Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Female Infertility Diagnosis and Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Female Infertility Diagnosis and Treatment Revenue in 2021
Figure 8. By Type - Global Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 12. US Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 24. China Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Female Infertility Diagnosis and Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Female Infertility Diagnosis and Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bristol-Myers Squibb Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Church & Dwight Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cook Medical Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. CooperSurgical Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Eli Lilly Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. EMD Serono Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Endo Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Ferring Pharmaceuticals Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Genea Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. GSK Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Halotech DNA Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Irvine Scientific Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Janssen Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Merck Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Novartis Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Origio Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Pfizer Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. OvaScience Female Infertility Diagnosis and Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)